Answers are grounded in this paper and cite their sources.
Background Breast cancer is biologically heterogeneous, and regulated cell death pathways may influence tumor development and treatment response. We aimed to prioritize genetically supported cell death-related molecular traits associated with breast cancer risk. Methods A curated set of 7,460 regulated cell death genes across 18 categories was integrated with methylation, expression, and protein quantitative trait loci and genome-wide association data for overall, estrogen receptor (ER)-positive, and ER-negative breast cancer. Summary-data-based Mendelian randomization, HEIDI filtering, and colocalization were used for discovery. Prioritized signals were examined in the UK Biobank self-reported overall breast cancer dataset; receptor-status-specific signals and alternative-instrument results were treated as exploratory lookups. FinnGen R12 served as an exploratory external lookup. Complementary analyses included breast tissue-specific SMR, tumor-based transcriptome-wide association testing with multiple-testing correction, descriptive single-cell and TCGA tumor-context analyses, cellular and tissue experiments, and survival reanalysis. Results ULK3 showed convergent discovery-stage evidence across all three molecular layers, including supportive pQTL-GWAS colocalization, whereas SNUPN and other candidates showed distinct cross-omics profiles. ULK3 did not meet the UK Biobank external-evaluation criteria, while RALB-related signals showed nominal external support. Exploratory FGF2, SEMA4A, ASIP, and alternative-instrument BTN3A1 UK Biobank lookups were null. Multiple-testing-corrected TWAS supported ULK3, SNUPN, SEMA4A, and RALB. Single-cell visualization indicated relatively higher ULK3 and SNUPN expression in immune populations, particularly T cells. ULK3 expression was lower in breast cancer cell lines than in MCF-10A cells. Quantitative IHC summaries provided descriptive tissue-expression context. Continuous ULK3 expression was not associated with overall survival; nominal cutoff-based evidence attenuated after selection correction and was absent in an expanded cohort. Higher MAP1LC3B transcript and total LC3B protein abundance in cells with lower ULK3 expression indicated altered autophagy-related marker expression but did not establish autophagic flux or autophagy-dependent cell death. Conclusion ULK3 is a genetically prioritized, potential autophagy-related candidate associated with breast cancer risk. Functional and independent validation is required.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: